CAS 2761969-44-0 Angiotensin II Human TFA

Xa kev nug
CAS 2761969-44-0 Angiotensin II Human TFA
Paub meej
CAS: 2761969-44-0 Nr
Cov qauv tseem ceeb: Trifluoroacetate ntsev daim ntawv ntawm haiv neeg octapeptide angiotensin II, nrog ib ntus ua raws li cov neeg endogenous angiotensin II (valine ntawm txoj hauj lwm 5), linear unmodified peptide. Daim ntawv trifluoroacetate txhim kho kev ua kom huv si thiab kev ruaj ntseg cia, thiab khi rau angiotensin AT₁ thiab AT₂ receptors nrog siab affinity raws li lub hauv paus effector ntawm renin -angiotensin system.
Peb kuj muab cov lus qhia tshwj xeeb los ntawm crude mus rau 99% purity, thov hu rau peb kom paub meej!
** Cov ntaub ntawv ntsig txog **
COA/MS/HPLC Report
Peptide Dissolution thiab Cia Phau Ntawv Qhia
Kev faib tawm yam khoom
Pharmaceutical Peptides
Share to
Hauj lwm lawm

Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas 2761969-44-0 angiotensin ii tib neeg tfa hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas 2761969-44-0 angiotensin ii human tfa los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

Khoom npe CAS 2761969-44-0 Angiotensin II human TFA
Kev piav qhia Angiotensin II yog cov tseem ceeb effector peptide ntawm renin -angiotensin-aldosterone system (RAAS). Los ntawm tshwj xeeb khi rau AT₁ receptors nyob rau hauv vascular du nqaij, lub raum thiab adrenal cov ntaub so ntswg, nws mediates muaj zog vasoconstriction, txhawb aldosterone synthesis thiab tso tawm, txhim khu lub raum tubular sodium reabsorption thiab elevates ntshav siab, thiab kuj koom nrog rau hauv pathological dab xws li vascular remodeling, inflammatory teb thiab cov ntaub so ntswg fibrosis. Cov khoom no yog ib tug trifluoroacetate formulation ntawm haiv neeg tib neeg ib theem zuj zus nrog kev ua tau zoo raws li endogenous human angiotensin II. Nws yog cov cuab yeej classic peptide rau cov kws kho mob plawv, ntshav siab mechanism thiab RAAS kev ua haujlwm kev tshawb fawb, thiab kuj tau siv dav hauv cov tshuaj tiv thaiv kev mob ntshav siab lub hom phiaj kev tshuaj ntsuam xyuas thiab kev ntsuas kev ua tau zoo.
Peptide Purity (HPLC, %) 95% / 98% / 99%
Dawb puag molecular mis C₅₀H₇₁N₁₃O₁₂
Dawb puag molecular hnyav (Da) 1046.18, siab dua rau TFA ntsev daim ntawv
Hom qauv Linear octapeptide, ib txwm tib neeg kab ke, trifluoroacetate ntsev

 

Product Basic Information Table

 

Khoom Lub Npe Lus Askiv Product Abbreviation / Alias Function Tags (comma-sib cais) Core Structure Molecular Formula Exact Mass (Da) Qhov nruab nrab MW (Da) Daim ntawv ntsev Ntev (aa)
Angiotensin II human TFA Human angiotensin II TFA AT₁/AT₂ receptor agonist, vasoconstrictive & hypertensive, RAAS system tshawb fawb cov cuab yeej Tib neeg octapeptide ib ntus (Val ntawm txoj hauj lwm 5), linear unmodified, core effector ntawm renin -angiotensin system; TFA ntsev txhim kho purification stability Dawb peptide: C₅₀H₇₁N₁₃O₁₂ 1045.54 1046.18 Trifluoroacetate (TFA) 8

Physicochemical Solubility & Cia Parameters

 

Khoom Code Qhov tshwm sim Ntev - Lub Sij Hawm Cia Luv - Lub Sij Hawm Cia Kev daws teeb meem Khoom hmoov ruaj khov
PEB-ANG202 hmoov dawb Khaws ntawm -20 degree, kaw, qhuav thiab tiv thaiv los ntawm lub teeb. Aliquot kom tsis txhob rov qab khov-thaw mus. ruaj khov rau 1 lub hlis ntawm 2-8℃nyob rau hauv kaw qhuav; nkoj ntawm cov pob khov nab kuab pom zoo. ruaj khov rau 7 hnub ntawm 4 degree. Cov dej solubility nruab nrab, pab los ntawm dilute acetic acid thiab acidic buffers. Cov tshuaj aqueous yog degraded sai sai los ntawm peptidases; npaj tshiab ua ntej siv. ruaj khov rau 3 xyoos ntawm -20 degree, qhuav thiab tiv thaiv los ntawm lub teeb.

Functional Description

 

Khoom Code Frontend Short Summary (rau cov npe tshawb nrhiav) Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg Cov cheeb tsam tshawb fawb (comma- cais) Lub Hom Phiaj / Txoj Kev
PEB-ANG202 Native tib neeg angiotensin II, core effector peptide ntawm RAAS system nrog lub zog vasoconstrictive thiab hypertensive teebmeem Angiotensin II yog cov tseem ceeb effector peptide ntawm renin -angiotensin-aldosterone system (RAAS). Los ntawm tshwj xeeb khi rau AT₁ receptors nyob rau hauv vascular du nqaij, lub raum thiab adrenal cov ntaub so ntswg, nws mediates muaj zog vasoconstriction, txhawb aldosterone synthesis thiab tso tawm, txhim khu lub raum tubular sodium reabsorption thiab elevates ntshav siab, thiab kuj koom nrog rau hauv pathological dab xws li vascular remodeling, inflammatory teb thiab cov ntaub so ntswg fibrosis. Cov khoom no yog ib tug trifluoroacetate formulation ntawm haiv neeg tib neeg ib theem zuj zus nrog kev ua tau zoo raws li endogenous human angiotensin II. Nws yog cov cuab yeej classic peptide rau cov kws kho mob plawv, ntshav siab mechanism thiab RAAS kev ua haujlwm kev tshawb fawb, thiab kuj tau siv dav hauv cov tshuaj tiv thaiv kev mob ntshav siab lub hom phiaj kev tshuaj ntsuam xyuas thiab kev ntsuas kev ua tau zoo. Kev tshawb fawb txog kev mob ntshav siab, RAAS txoj haujlwm ua haujlwm, kev tshawb fawb txog tshuaj kho plawv, tshuaj tiv thaiv kab mob ntshav siab & tshuaj ntsuam xyuas, vascular remodeling & fibrosis tshawb fawb Angiotensin II hom 1 receptor (AT₁R), hom 2 receptor (AT₂R); Vasoconstriction thiab dej -sodium metabolism kev tswj txoj hauv kev

 

 

 

 

 

 

 

 

 

Cim npe nrov: CAS 2761969-44-0 angiotensin ii human tfa, Tuam Tshoj cas 2761969-44-0 angiotensin ii human tfa manufacturers, lwm tus neeg, Hoobkas

Xa kev nug